X

Articles

Basaglar no longer covered through Pacific Source and Trillium.

Basaglar (insulin glargine) will no longer be covered through Pacific Source(2/1/24) and Trillium (4/1/24).  Alternative covered glargine formulations are Lantus and Rezvoglar.  Encourage your patients to choose Lantus when switching from Basaglar. Lantus also has favorable 340B pricing.

Pacific Source Community Solution 2024 Insulin Change

 

Covered Now 

Must be switched to by 2/15 

Conversion considerations  

Long acting 

Basaglar*  

Rezvoglar(insulin glargine-aglr)  

OR  

Lantus

OR

Insulin degludec 

Consider insulin degludec U200 insulin for patients on 60 units/day or more. This will allow for a lower volume to be injected and for continuation of once daily dosing as this pen dials to 160units. Of note,  U200 insulin pen dials in 2 unit increments. Insulin degludec has a longer half life, and missed doses can be injected late as long as there is 8 hrs until the next dose.

As a reminder, basal insulin dosing should be capped at 0.5units/kg or FBG goal, whichever occurs first, to avoid overbasalization.

A 20% dose reduction if switching to insulin degludec if patient currently controlled or at risk for hypoglycemia. After initial dose reduction, titrating back up may be necessary depending on response. 

  • Basaglar cannot be changed automatically by the pharmacy to Rezvoglar or Lantus

 

Reported by:

Sara Jones, Pharm D.

Consulting Pharmacist

Northwest Human Services

 

 

The 340B Drug Pricing Program is managed by the Health Resources and Services Administration (HRSA) Office of Pharmacy Affairs (OPA). For more information visit: www.hrsa.gov/opa This material is provided for general informational purposes of 340B Drug Prices only and is not an endorsement of any prescription product referenced herein. For information as to the clinical use or efficacy of a referenced product, please contact the manufacturer. 340B Price Guide makes no representations and provides no warranties as to the effectiveness or suitability for use of any prescription product referenced herein. Any referenced cost is provided as an estimate only and the actual cost is subject to change at any time and without notice. 340B Price Guide does not guarantee that the cost represented herein will be the actual and pharmacy shall at all times collect amounts due as indicated at the time of adjudication and shall be reimbursed per the terms of its agreement.'